Healthtech Solutions (OTC: HLTT), through its subsidiary, Mediscan Inc., offers cloud-based software for ultrasound that has proven to be effective in evaluating internal organs affected by COVID-19. “COVID-19 has shown a propensity to affect an individual’s body in a number of different ways, including the long-term health of a patient’s cardiovascular and pulmonary system,” reads an article discussing the company’s solution. “As such, the need to properly diagnose lung infections, which could otherwise be sustained throughout a patient’s life, or myocarditis, an inflammation of the heart muscles, which could go undiscovered if not properly diagnosed, has heightened the need for medical practitioners to make use of proper technology to enable early diagnosis.” Mediscan’s software is ideal to assist in this task. It “has shown great success in musculoskeletal (‘MSK’), lung and cardiac imaging, enabling rapid pathology evaluation. Scanning the lung or the MSK sub-system, Mediscan directly images the target area being checked, saves it as a reference, and then automatically compares it to previous images. This enables it to determine the changes in a patient’s condition.”
To view the full article, visit https://ibn.fm/AtXxN
Healthtech Solutions Inc.
Healthtech Solutions, through its subsidiary, Mediscan Inc., offers technology that can transform 2D images from a portable ultrasound machine into digital 3D images to provide better diagnosis and more accurate internal trauma views. The technology has multiple applications in lung, cardiac and musculoskeletal imaging and related uses. For more information, visit the company’s website at www.MyMediScan.com.
NOTE TO INVESTORS: The latest news and updates relating to HLTT are available in the company’s newsroom at https://ibn.fm/HLTT
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
For more information, please visit https://www.InvestorWire.com
InvestorWire is part of the InvestorBrandNetwork.